SCOLR Pharma Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2009. Total revenues, which consist of royalty revenue from collaboration agreements, increased 11%, or $25,343 to $261,651 for the three months ended September 30, 2009, compared to $236,308 for the same period in 2008. Net loss increased $2.5 million to $1.6 million or $0.04 per basic and diluted share for the three months ended September 30, 2009, compared to $890,371 of net income or $0.02 per basic and diluted share for the same period in 2008. The company reported loss from operations of $1,585,634 compared to income from operations of $847,814 for the same period of last year. Total revenues decreased 15%, or $117,223 to $664,212 for the nine months ended September 30, 2009, compared to $781,435 for the same period in 2008. Net loss for the nine months ended September 30, 2009, increased 57%, or $1.8 million to $5.1 million or $0.12 per basic and diluted share, compared with a net loss of $3.2 million or $0.08 per basic and diluted share for the same period in 2008. The increased net loss reflects the net impact of the non-recurring $4.0 million income recognized in the prior year for the facility lease buyout. The company reported loss from operations of $5,071,095 compared to loss from operations of $3,411,261 for the same period of last year.

SCOLR Pharma Inc. named Stephen Turner as president and chief executive officer. He had been vice president and chief technical officer since 2003. Bruce Morra, who had held the presidency and CEO post, continues as a director.

SCOLR Pharma Inc. announced that on September 15, 2009, the NYSE AMEX LLC (the Exchange) accepted the Company's plan of compliance with respect to its previously disclosed listing deficiency as set forth in Section 1003(a)(iii) of the Exchange Company Guide. Such deficiency relates to the Company's failure to maintain stockholder's equity of at least $6,000,000 and losses from continuing operations and net losses incurred during the five most recent fiscal years. In accordance with applicable Exchange requirements, the Company submitted a plan of compliance to the Exchange on July 28, 2009 (with several intervening supplements) setting forth the actions it has taken or would take to bring the Company into compliance with the standard set forth in Section1003(a)(iii) of the Exchange Company guide. On September 15, 2009 the Exchange notified the Company that it accepted the Company's plan of compliance with the continued listing requirements of Section 1003(a)(iii) and granted the Company an extension until December 27, 2010 to regain compliance with such requirement. The Company will be required to provide the Exchange staff with updates in conjunction with the initiatives of the plan of compliance on a regular basis and the Exchange staff will review the Company periodically during the extension period to assess progress against the plan of compliance. Failure to make progress consistent with the plan or to regain compliance with the continued listing standards by the end of the extension period could result in the Company being delisted from the Exchange. The Company also reported that on September 15, 2009, it received a separate notice from the Exchange stating that the Company does not meet the continued listing standard set forth in Section 1003(a)(iv) of the Company Guide because, based on the Exchange's review of the Company's Form 10-Q for the period ending June 30, 2009, the Company has sustained losses which are so substantial in relation to its overall operations or its existing financial resources, or its financial condition has become so impaired that it appears questionable, in the opinion of the Exchange, as to whether the Company will be able to continue operations and/or meet its obligations as they mature. The Company may submit a further supplement to its compliance plan no later than October 15, 2009, to address how it intends to regain compliance with Section 1003(a)(iv) of the Company Guide by March 15, 2010. The Exchange will evaluate the plan, including any supplements, and determine whether the Company has made a reasonable demonstration of its ability to regain compliance with the listing standard set forth in Section 1003(a)(iv) by March 15, 2010. There can be no assurance that the Company's plan will be accepted. If the Company's compliance Plan, as updated to address the additional deficiency is not accepted by the Exchange, or if the Plan is accepted but the Company is not in compliance with the continued listing standards within the appropriate time period, or if the Company does not make progress consistent with the plan during the plan period, then the Exchange may initiate delisting proceedings.